Straight From the Cutter's Mouth

    Daniel Chao and Dr. Shriji Patel join to discuss 3 recent articles in JAMA Ophthalmology regarding drug prices in the US and Australia, SCORE2 secondary analysis results and statins for diabetic retinopathy.

    Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alimera, Alcon and Allergan. Dr. Chao is a consultant for Recens Medical Inc., DTXPharma, Allergan, Visgenx and Zilia, and receives research funding from the National Eye Institute, Bright Focus Foundation, Clearside Biomedical Inc., Chengdu Pharmaceuticals, Opthea Ltd, Genentech and Apellis Pharmaceuticals.